Literature DB >> 24659310

New proposed guidelines for early identification of successful myeloid and erythroid engraftment in hematopoietic stem cell transplantation.

Seung-Ah Yahng1, Jae Wook Lee, Yonggoo Kim, Myungshin Kim, Eun-Jee Oh, Yeon-Joon Park, Jong Wook Lee, Bin Cho, Kyungja Han.   

Abstract

BACKGROUND: After hematopoietic stem cell transplantation (HSCT), early detection of engraftment would be of critical value for clinicians. The aim of this study was to identify faster parameters for engraftment.
METHODS: We evaluated blood cell parameters including complete blood count (CBC), differential counts, and various reticulocyte parameters in 115 patients who received HSCT (allogeneic, n = 93; autologous, n = 22) in the purpose of identifying possible improved laboratory guidelines for engraftment prediction. RESULTS AND
CONCLUSION: Days to white blood cell (WBC) count over 100 cells/μl with more than two-fold increase from nadir after transplantation (proposed new WBC guideline) preceded absolute neutrophil count (ANC) >500 cells/μl by 1.7 days. Among erythroid parameters, the earliest marker for erythroid engraftment was high light scattering reticulocytes (HLR) >0.1 (proposed new red blood cell guideline), which preceded reticulocyte counts (RET) >1% and immature reticulocyte fraction >0.5 by 3.9 and 1.6 days, respectively. Among the clinical parameters compared, those with statistically significant influence on myeloid engraftment were donor type (P = 0.009) and conditioning intensity (P = 0.009). As for erythroid recovery, ABO incompatibility was the only significant factor. In conclusion, the new guidelines may ensure engraftment several days earlier than the conventional parameters, which may help clinicians for decision-making on rescue therapy earlier.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HLR; erythroid engraftment; hematopoietic stem cell transplantation; myeloid engraftment; reticulocytes

Mesh:

Year:  2014        PMID: 24659310      PMCID: PMC6807356          DOI: 10.1002/jcla.21712

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  15 in total

1.  Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.

Authors:  Regula J Mueller; Georg Stussi; Bernhard Odermatt; Jörg Halter; Urs Schanz; Jörg D Seebach
Journal:  Xenotransplantation       Date:  2006-03       Impact factor: 3.907

2.  Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators for acute bacterial infection.

Authors:  Fernando Chaves; Bethany Tierno; Dongsheng Xu
Journal:  Am J Clin Pathol       Date:  2005-09       Impact factor: 2.493

3.  Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.

Authors:  M L Grazziutti; L Dong; M H Miceli; M Cottler-Fox; S G Krishna; A Fassas; F van Rhee; B M Barlogie; E J Anaissie
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

4.  Neutrophil volume distribution width: a new automated hematologic parameter for acute infection.

Authors:  Fernando Chaves; Bethany Tierno; Dongsheng Xu
Journal:  Arch Pathol Lab Med       Date:  2006-03       Impact factor: 5.534

5.  Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation.

Authors:  Marjorie L Zucker; Carol A Murphy; Jane M Rachel; Gregory A Martinez; Sunil Abhyankar; Joseph P McGuirk; Kimberly J Reid; Fred V Plapp
Journal:  Lab Hematol       Date:  2006

6.  Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.

Authors:  Je-Hwan Lee; Jung-Hee Lee; Seong-Jun Choi; Shin Kim; Miee Seol; Seog-Woon Kwon; Chan-Jeoung Park; Hyun-Sook Chi; Jung-Shin Lee; Woo-Kun Kim; Kyoo-Hyung Lee
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

7.  Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Authors:  Grzegorz Helbig; Beata Stella-Holowiecka; Malgorzata Krawczyk-Kulis; Jerzy Wojnar; Miroslaw Markiewicz; Maria Wojciechowska-Sadus; Malgorzata Kopera; Tomasz Kruzel; Jacek Najda; Katarzyna Nowak; Jerzy Holowiecki
Journal:  Haematologica       Date:  2005-11       Impact factor: 9.941

8.  Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.

Authors:  J Dubovsky; H Daxberger; G Fritsch; D Printz; C Peters; S Matthes; H Gadner; T Lion; N Muller-Bérat
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

9.  Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.

Authors:  V Pullarkat; S Blanchard; B Tegtmeier; A Dagis; K Patane; J Ito; S J Forman
Journal:  Bone Marrow Transplant       Date:  2008-09-01       Impact factor: 5.483

10.  Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.

Authors:  Anuj Mahindra; Brian Bolwell; Ronald Sobecks; Lisa Rybicki; Brad Pohlman; Robert Dean; Steve Andresen; John Sweetenham; Matt Kalaycio; Edward Copelan
Journal:  Br J Haematol       Date:  2009-06-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.